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Abstract
Background: Thionins are a family of plant antimicrobial peptides (AMPs), which participate in plant defense
system against pathogens. Here we describe some aspects of the CaThi thionin-like action mechanism, previously
isolated from Capsicum annuum fruits. Thionin-like peptide was submitted to antimicrobial activity assays against
Candida species for IC50 determination and synergism with fluconazole evaluation. Viability and plasma membrane
permeabilization assays, induction of intracellular ROS production analysis and CaThi localization in yeast cells were
also investigated.
Results: CaThi had strong antimicrobial activity against six tested pathogenic Candida species, with IC50 ranging
from 10 to 40 μg.mL−1. CaThi antimicrobial activity on Candida species was candidacidal. Moreover, CaThi caused
plasma membrane permeabilization in all yeasts tested and induces oxidative stresses only in Candida tropicalis.
CaThi was intracellularly localized in C. albicans and C. tropicalis, however localized in nuclei in C. tropicalis,
suggesting a possible nuclear target. CaThi performed synergistically with fluconazole inhibiting all tested yeasts,
reaching 100 % inhibition in C. parapsilosis. The inhibiting concentrations for the synergic pair ranged from 1.3 to
4.0 times below CaThi IC50 and from zero to 2.0 times below fluconazole IC50.
Conclusion: The results reported herein may ultimately contribute to future efforts aiming to employ this plant-
derived AMP as a new therapeutic substance against yeasts.
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Background
Currently, a significant global public health threat is the
emergence of pathogenic bacteria, fungi, and yeasts that
are resistant to multiple antimicrobial agents. Indeed,
few or no effective chemotherapies are available for in-
fections caused by some of these resistant microorgan-
isms [1, 2].
Alternatives to chemotherapies include antimicrobial
peptides (AMPs), small molecules produced by all living
organisms, which have gained considerable attention
because of their potent antimicrobial activity against a
broad range of microbes, including viruses, bacteria,
protozoa, and fungi [3, 4]. Moreover, some kill microor-
ganisms rapidly, are able to synergize with other AMPs
and clinical antibiotics, have low toxicity to mammalian
cells, and exert their microbial inhibitory activity at low
concentrations. These molecules have multiple targets in
the plasma membrane and also in intracellular compo-
nents, which is thought to make an increase in microbial
resistance more difficult [2, 5].
Promising AMPs include plant-derived thionins, a
family of basic, low molecular weight (~5 kDa), cysteine-
rich peptides. Various family members have high
sequence similarity and structure [6–8]. Many of them
* Correspondence: valmg@uenf.br
1Laboratório de Fisiologia e Bioquímica de Microrganismos, Centro de
Biociências e Biotecnologia, Universidade Estadual do Norte Fluminense,
Campos dos Goytacazes 28013-602, RJ, Brazil
Full list of author information is available at the end of the article
© 2016 Taveira et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Taveira et al. BMC Microbiology  (2016) 16:12 
DOI 10.1186/s12866-016-0626-6
Table 1 IC50
a (μg.mL−1) of fluconazole and CaThi in different
species of Candida respectively
Yeasts Fluconazole CaThi
Candida albicans (CE022) 1.0 10.0
Candida tropicalis (CE017) 1.0 10.0
Candida parapsilosis (CE002) 0.5 10.0
Candida pelliculosa (3974) 5.0 40.0
Candida buinensis (3982) 0.125 10.0
Candida mogii (4674) 2.5 20.0
a represents the concentration of a drug that is required for 50 %
inhibition in vitro
Taveira et al. BMC Microbiology  (2016) 16:12 Page 2 of 13are toxic against yeasts, pathogenic fungi, Gram-positive
and Gram-negative bacteria, protozoa, and insects [7–
10]. Like other AMPS, thionins’ antimicrobial activity re-
lies on their interaction with phospholipids to cause
membrane instability [10].
Infections caused by Candida species have increased
substantially over the last 30 years due to the rise of
AIDS, ageing population, numbers of immunocomprom-
ised patients and the extensive use of indwelling pros-
thetic devices [1, 11]. Candida albicans is the main
cause of candidiasis, however, other Candida species
such as C. tropicalis, C. parapsilosis, and C. glabrata are
now frequently identified as human pathogens [11–13].
Antifungals, especially fluconazole (FLC), have been
used with some success for the treatment of Candida
infections; however, there are numerous reports on the
emergence of strains resistant to azoles that overexpress
multidrug efflux transporters [14, 15].
In a previous report [8], our research team isolated a
plant-derived thionin, named CaThi, with strong anti-
microbial activity against two pathogenic Candida spe-
cies, as well as Escherichia coli and Pseudomonas
aeruginosa. FLC in combination with AMPs resulting in
promising therapeutic results against important human
pathogens, such as C. albicans and Cryptococcus neofor-
mans, has been demonstrated [16, 17]. In this work we
investigated whether the AMP CaThi could act synergis-
tically with FLC. This synergistic strategy could result in
a more efficient response against six Candida strains of
clinical importance, avoiding the cytotoxic effects com-
monly exhibited by thionins against mammalian cells
[10] by using low concentrations of this AMP. We were
also interested in understanding the mechanism by
which plant-derived thionins affect Candida species,
which remains partially unknown [10]. These questions
are addressed in the present study.
The results reported herein may ultimately contribute
to future efforts aiming to develop this plant-derived
AMP as a new therapeutic substance against these patho-
genic Candida species as well as other yeast infections.
Results
Determination of IC50 for CaThi and FLC
Initially we performed growth inhibition assays of six
Candida species using different concentrations of FLC
and thionin CaThi to determine the IC50 of these sub-
stances. The lowest IC50 for FLC was found for C. bui-
nensis (0.125 μg.mL−1) and the highest for C. pelliculosa
(5 μg.mL- 1). In the case of CaThi, 10 μg.mL−1 was suffi-
cient to cause 50 % inhibition of growth of C. albicans,
C. tropicalis, C. parapsilosis, and C. buinensis but
40 μg.mL−1 was necessary to achieve IC50 for C. pellicu-
losa. Thus, higher concentrations of both FLC and
CaThi were needed to affect the growth of C. pelliculosa.Moreover, although the antimicrobial activity of CaThi
against Candida species is indeed relevant, our data
showed it to be lower than that observed for FLC
(Table 1).
Viability assay
CaThi induced viability loss in all yeasts cells tested
(Fig. 1a). The most susceptible species to CaThi were C.
buinensis, C. parapsilosis and C. albicans with 99.2, 98.9
and 80.3 % of viability loss, respectively, and the less sus-
ceptible was C. tropicalis with 47.9 % of viability loss
(Fig. 1b). These results indicated that inhibitory effect of
CaThi was candidacidal.
Plasma membrane permeabilization
Candida species cells were tested to determine the mem-
brane permeabilization by Sytox green dye. All yeasts
showed Sytox green fluorescence when grown for 24 h in
the presence of CaThi IC50. As with other AMPs, it is
likely that CaThi acts on the plasma membrane of these
Candida species, compromising it structurally and allow-
ing the permeabilization of the labeling dye (Fig. 2). The
membrane permeabilization percentage of the treated
yeasts with CaThi was assessed (Table 2). A higher num-
ber of C. albicans and C. pelliculosa cells presented higher
Sytox green fluorescence percentage, suggesting that
CaThi is more effective at permeabilizing the membrane
of these cells than the other Candida species analyzed.
ROS induction assay
Endogenous production of ROS was analyzed by incu-
bating the yeasts for 24 h with CaThi IC50. Increased
ROS production was observed only in C. tropicalis
(Fig. 3), suggesting that a CaThi-induced increase in oxi-
dative stress may underlie the growth inhibitory effect
on this yeast. Nevertheless, oxidative stresses were not
detected for other Candida species, implicating that we
could not associate the CaThi role and ROS production
with growth inhibition of Candida, at least for the
concentrations tested.
Fig. 1 Cell viability loss. a Photographs of the Petri dishes showing the viability of yeasts cells after the treatment with IC50 CaThi for 24 h. b The
table shows the percentage of viability loss of yeasts cells after the treatment with IC50 CaThi for 24 h. CFU = Colony forming unit. (*) Indicates
significance by the T test (P < 0.05) among the experiments and their respective controls. The experiments were carried out in triplicate
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We also investigated whether CaThi was actually internal-
ized in C. albicans and C. tropicalis cells. These yeasts were
chosen because they are known to be the most opportunistic
pathogens among Candida species. Another important
point is that C. tropicalis was the only yeast that presented
membrane permeabilization and induction of ROS by CaThi
in this work. To perform the test, we used 10 μg.mL−1 ofFITC-tagged CaThi to search for intracellular signal fluores-
cence. We also treated the cells with DAPI for nuclei label-
ing. Intracellular signal fluorescence of CaThi-FITC was
observed in both of these Candida species. However, while
CaThi-FITC labeling of C. tropicalis produced a specific and
intense spot of fluorescence inside the cells, C. albicans cells
showed a more diffuse fluorescence. Overlapping of
these CaThi-FITC images with DAPI nuclei labeling
Fig. 2 Membrane permeabilization assay. Photomicrography of different yeast cells after membrane permeabilization assay by fluorescence
microscopy using the fluorescent probe Sytox green. Cells were treated with CaThi for 24 h and then assayed for membrane permeabilization.
Control cells were treated only with probe Sytox green. Bars 5 μm
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in C. tropicalis but not in C. albicans cells (Fig. 4).
These data suggest that, at least for C. tropicalis,
CaThi may have an intracellular target, possibly lo-
cated in the nucleus.
Synergism assay
Given the increase in Candida infections, particularly
among immunocompromised patients, searches for anti-
fungal therapeutic alternatives are warranted. This
concern and the aforementioned data prompted us to
investigate whether FLC and CaThi could act synergistic-
ally to improve therapeutic results against Candida
species. The combination of FLC and CaThi showed an
increase in inhibitory activity of all of the Candida spe-
cies tested, suggestive of synergistic activity (Table 3).
Interestingly, although C. pelliculosa had the highest IC50
for both substances, when we combined FLC at one-foldbelow its IC50 and CaThi at threefold below its IC50, we
observed 57 % increase in growth inhibition of this yeast.
Similarly, in C. parapsilosis cells, when IC50 FLC was
combined with CaThi threefold below its IC50, we ob-
tained 100 % growth inhibition of this yeast. Combined
use of FLC and CaThi also strongly inhibited (96 %) C.
tropicalis, although when used separately the inhibition
achieved with these substances did not reach 12 %. Taken
together, these data suggest that in combination FLC and
CaThi could have an important synergistic action result-
ing in very effective control of Candida species.
Morphological alterations of CaThi and FLC plus CaThi on
yeast growth
Investigation regarding the possible morphological alter-
ations in yeast cells grown in the presence of FLC,
CaThi, or a combination of both substances after the
inhibition assays (Fig. 5a) was performed. Optical
Table 2 Fluorescent cell percentage of yeasts treated with CaThia
Yeasts species Sample Cell number viewed in DIC Cell number viewed in fluorescence % of fluorescence cellsb
C. albicans control 62.0 ± 9.3 0.6 ± 0.8 0.9
CaThi 20.0 ± 5.0 16.6 ± 5.3 83.0
C. tropicalis control 41.2 ± 4.2 0.8 ± 1.3 1.9
CaThi 9.8 ± 4.9 4.8 ± 4.6 48.9
C. parapsilosis control 79.2 ± 12.1 0 0
CaThi 18.2 ± 5.4 6.2 ± 1.4 34.0
C. pelliculosa control 23.8 ± 3.5 0 0
CaThi 7.2 ± 1.9 6.6 ± 2.3 91.6
C. buinensis control 43.6 ± 9.0 0.8 ± 1.3 1.8
CaThi 13.6 ± 6.2 6.2 ± 1.3 45.5
C. mogii control 18.6 ± 3.2 0.6 ± 0.8 3.2
CaThi 8.6 ± 2.0 4.4 ± 2.7 51.1
aCells number determination in five random fields of the DIC and fluorescence views of the samples obtained from Plasma membrane permeabilization assay. The
total cell number in DIC of each yeast (in control and test) was assumed as 100 %
bIndicates significance by the T test (P < 0.05) among the experiments and their respective controls
Fig. 3 Oxidative stress assay. Photomicrography of different yeast cells after reactive oxygen species assay detection by fluorescence microscopy
using the fluorescent probe 2 ,7 dichlorofluorescein diacetate (H2DCFDA). Cells were treated with CaThi for 24 h and then assayed for ROS
detection. Control cells were treated only with probe (H2DCFDA). Bars 5 μm
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Table 3 Inhibition percentage of yeast species treated with CaThi and FLC alone and in combination showing synergism effect
in vitro
Yeasts species Sample Concentration (μg.mL−1)a Inhibition (%) Combination inhibition (%) (CaThi + FLC)b
C. albicans CaThi 3.5 2.93 77.5
FLC 0.5 24.48
C. tropicalis CaThi 3.5 0 96.26
FLC 0.5 11.55
C. parapsilosis CaThi 3.5 4.0 100.0
FLC 0.5 50
C. pelliculosa CaThi 15.0 2.63 57.45
FLC 2.5 7.8
C. buinensis CaThi 5.0 19.0 67.01
FLC 0.06 5.45
C. mogii CaThi 10.0 17.19 61.05
FLC 1.0 22.80
aCaThi concentrations ranging 1.3 to 4.0 times below it IC50 and FLC concentrations 2.0 times below it IC50 or at it IC50
bIndicates significance by the ANOVA test (P < 0.05) which were calculated by the absorbance values of synergism among the experiments and their
respective controls
Fig. 4 Localization of CaThi in yeast cells. Photomicrography of Candida albicans and Candida tropicalis cells incubated for 24 h with 10 μg.mL−1
CaThi-FITC (green fluorescence, open arrows) by fluorescence microscopy. Nuclei were visualized by 4 ,6-diamidino-2-phenylindole
dihydrochloride (DAPI) after the CaThi-FITC incubation period (blue fluorescence, filled arrows). Overlap of the DAPI and FITC images (dotted
arrows). Bars 20 μm. (*) Indicates the position of digital enlargement
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Fig. 5 Effect of CaThi, FLC, and CaThi plus FLC on yeast growth. a Photomicrography of Candida albicans, Candida tropicalis, Candida parapsilosis,
Candida pelliculosa, Candida buinensis, and Candida mogii cells by light microscopy after the growth inhibition assay. Bars 5 μm. b Scanning
electron microscopy of Candida pelliculosa and Candida buinensis. Filled arrow (formation of pseudohyphae); open arrow (cell agglomeration);
asterisk (amorphous material). Bars 10 μm. Cells grown in the presence of Fluconazole (FLC), CaThi, and FLC plus CaThi
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combined treatment caused changes in the morphology
of cells of Candida species. C. tropicalis, C. parapsilosis,
C. pelliculosa, and C. mogii exhibited an apparent
difficulty in releasing buds thus leading to the formation
of pseudohyphae when grown in the presence of CaThi.
Moreover, in the presence of either substance, C. tropi-
calis cells presented hyper branching of pseudohyphae.
For C. albicans and C. buinensis, an intense cellular
agglomeration in all treatments was observed. Further,
the combination of CaThi and FLC caused a shrunken
appearance in C. albicans cells.
Scanning Electronic Microscopy (SEM) of C. pelliculosa
reinforces the optical microscopy observations, corre-
sponding to intense cell agglomeration and pseudohyphae
formation in all treatments. For C. buinensis, all treat-
ments showed intense cellular agglomeration and appar-
ent difficulty in bud release, but not in the formation of
pseudohyphae. For this yeast an amorphous material
among cells in all treatments was also observed (Fig. 5b).
These results show that CaThi is capable of causing mor-
phological changes similar to FLC, an azole antifungal
agent, commonly used in treatment of infections caused
by Candida species. Importantly, we were able to demon-
strate that the combination of these substances potentiates
the therapeutic effects against these opportunistic species
of Candida.Discussion
Plant-derived thionins exhibit toxic effects against a wide
range of plant pathogens including bacteria and fungi
[18–21]. However, there is a gap regarding the mode of
action of plant-derived thionins against human patho-
gens. Prompted by the considerable increase in the inci-
dence of human infections by Candida species, we
investigated the potential of CaThi, a plant-derived thio-
nin peptide, as a novel therapeutic drug against six Can-
dida strains of clinical interest: C. albicans, C. tropicalis,
C. parapsilosis, C. pelliculosa, C. buinensis, and C. mogii.
The growth inhibition assay was not done with RPMI
1640 medium, which is generally indicated by Clinical
and Laboratory Standards Institute guidelines, because it
has in its composition a large amount of inorganic salts
and it is well known in the literature that the presence
of salts, such as sodium chloride and magnesium sulfate,
can decrease the inhibitory activity of antimicrobial
peptides since it is necessary electrostatic approximation
of the peptide with the membrane of microorganisms
and the presence of salts disrupts this initial interaction
[22–24]. Therefore, as explained above, our growth in-
hibition assay was done with Sabouraud broth which is a
common used medium to growth of fungi, including
Candida albicans.Our growth inhibition assays of the six Candida
species tested revealed that 10 μg.mL−1 was IC50 for CaThi
to inhibit the growth of C. albicans, C. tropicalis, C. para-
psilosis, and C. buinensis but 40 μg.mL−1 was necessary to
achieve IC50 for C. pelliculosa (Table 1), and this inhibitory
effect was candidacidal inducing viability loss in all yeast
cells tested (Fig. 1). Thi 2.1, a thionin from Arabidopsis
thaliana, achieved 80 % inhibition of C. albicans with
2.5 μg.mL−1 [25]. Although Thi 2.1 showed stronger anti-
microbial activity against C. albicans than CaThi, these
authors did not test it against non-albicans species. Thus,
whether this thionin would affect other species with similar
strength remains unknown.
Sytox green is a dye that only penetrates cells when
the plasma membrane is structurally compromised. All
yeast species tested showed Sytox green fluorescence
(Fig. 2), however CaThi was more effective in plasma
membrane permeabilization in C. albicans and C. pelli-
culosa (Table 2). Antimicrobial activity against the
fungus Neurospora crassa by α-Hodothionin, isolated
from barley seeds, also occurs via a mechanism involving
membrane permeabilization, resulting in the inward flux
of Ca2+ and K+ efflux and consequent potential mem-
brane collapse [26]. Another plant-derived thionin iso-
lated from Viscum album, named VtA3, interacts with
the plasma membrane of the fungus Fusarium solani,
causing its permeabilization and thus inhibiting the
growth of this microorganism [27]. Indeed, several stud-
ies suggest that most of the biological effects of thionins
result from the interaction of these peptides with the
target cell membrane. Three mechanisms have been
proposed: formation of an ion-selective channel; forma-
tion of patches or carpets of peptides; and loss of
membrane phospholipids [10].
AMPs have been demonstrated to play a direct role in
membrane permeabilization, causing a loss of membrane
potential [28]. As cells depend on membrane potential
to fulfill their physiological functions, its restoration is
mandatory and demands cellular energy. One possible
consequence of this process is ROS generation by
activated mitochondria [29]. Therefore, we analyzed
whether this primary membrane-permeabilizing event in
Candida species induced by CaThi was followed by
oxidative stress. Interestingly, CaThi only induced pro-
duction of ROS in C. tropicalis (Fig. 3). We speculate
that CaThi binds to a specific domain of the C. tropicalis
membrane, which triggers the increase in oxidative
stress response through ROS production. However, fur-
ther studies are needed to establish this. Reports show
that increase in ROS production by the target organisms
is a recurring mode of action employed by thionins and
other AMPs [27, 30, 31]. Indeed, increased death of the
fungus Fusarium solani subjected to VtA3 was con-
nected with boosted ROS production by these organisms
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from the beetle Psacothea hilaris also provoked in in-
crease in the levels of endogenous ROS in C. albicans
[32]. Our study is the first to report increase in ROS
production by a plant-derived thionin as an antimicro-
bial mechanism against a human pathogen, C. tropicalis.
Therefore, CaThi seems to employ a sophisticated
mechanism to inhibit the growth of this opportunistic
yeast involving not only membrane permeabilization but
also induction of oxidative stress response.
Some AMPs are able to enter the cell, after the
initial cell membrane interaction [33, 34]. Accord-
ingly, the next experiments were designed to analyze
whether CaThi was able to actively enter C. albicans
and C. tropicalis. In the approach used, FITC-tagged
CaThi was monitored by fluorescence microscopy.
Because CaThi entered C. albicans and C. tropicalis
cells, we suggest that a possible intracellular target
for this thionin might be part of a complex mechan-
ism responsible for the death of Candida species.
FITC-tagged CaThi overlapped with DAPI staining,
indicating that, in C. tropicalis, this target is nuclear
(Fig. 4). Giudici et al. [27] showed that VtA3 entered
and accumulated in the fungus F. solani. These au-
thors also demonstrated that this entry was related to
the sphingolipid composition of the plasma mem-
brane of this fungus. Our study is the first to show
that a plant-derived thionin (CaThi) is able to enter
human pathogens (C. albicans and C. tropicalis) and
to suggest an intracellular target for it. Our work
opens new perspectives regarding the antimicrobial
mechanism of plant-derived thionins as it suggests
that these peptides’ toxicity may not be restricted to
the plasma membrane.
The real mode of action of AMPs has not been fully
elucidated, but much of the described AMPs to date tar-
get the plasma membrane of microorganisms causing
pore formation and leading to imbalance in cellular
homeostasis [33, 35]. However, some studies showed
that not only is permeabilization the cause of a particu-
lar microorganism death, as they may have multiple
targets [36] after the interaction with the membrane
causing, for example, ROS induction [31, 37]; inhibition
of protein synthesis [38, 39]; inhibition of mitochondrial
activity [40, 41], and also may trigger signaling cascades
that lead to apoptosis [42, 43]. Thus it is difficult to
identify the most important factor for the candidacidal
effect of CaThi and is technically challenging to
characterize the steps leading up to cell death, however
evidence supports that all events described in the
manuscript may have a crucial role in the death of the
tested yeasts.
The continuous emergence of resistance of fungal
strains to conventional antibiotics and antifungals,especially Candida species, has become an important
medical issue and has spurred the demand for new
therapeutic alternatives. This concern prompted us to
investigate whether FLC and CaThi could act synergis-
tically to improve therapeutic results against Candida
species. Here we show that the combination of these
two substances was effective against all Candida species
tested (Table 3), causing drastic morphological changes
in these cells (Fig. 5). Interestingly, we show that the
inhibitory effect of this combination was more effective
for C. albicans, C. parapsilosis, and C. tropicalis, which
are the major yeast species recovered from infections in
immunocompromised patients [13]. The azoles mode of
action occurs by inhibition of the enzyme lanosterol 14
α-demethylase, blocking ergosterol incorporation and
leading to the accumulation of intermediate sterols.
These intermediate sterols do not have the same config-
uration and physical properties of ergosterol, therefore
they cause the plasma membrane to form with altered
properties, changing in fluidity, permeability and impair-
ing nutrient uptake, which ultimately lead to cell toxicity
[44, 45]. In regard to the synergistic effect of FLC and
CaThi, we hypothesize that permeabilization is firstly
caused by CaThi (Fig. 2) facilitating the entrance of FLC
into the cell cytoplasm, triggering structural alterations
in the plasma membrane which feedback positively to
the entrance of more CaThi and FLC. This entrance
creates potential for toxic effects, which were experi-
mentally observed in the lower IC50 used for both
substances in the combinatory treatment (Table 3). Add-
itionally, secondary toxicity effects were demonstrated,
such as the induction of ROS to C. tropicalis, the CaThi
presence in C. albicans cell cytoplasm and in C. tropica-
lis nuclei. These localizations suggest that CaThi may
have cytoplasmic targets, where interference could
consolidate the inhibitory effect. However, more studies
are necessary to clearly unravel the antimicrobial mech-
anism of CaThi against Candida species as well as the
mechanism of synergy between CaThi and FLC.
Conclusions
Investigating a plant-derived thionin mode of action
against opportunistic human pathogenic yeasts is rele-
vant and advisable, whereas most studies involving
plant-derived thionins focus their effects against plant
pathogenic microorganisms as experimental models. In
this report, we demonstrated that CaThi has strong can-
didacidal activity against six pathogenic Candida spe-
cies, and it works by permeabilizing the membrane and
inducing oxidative stress response in these yeasts. Add-
itionally, we present evidence to suggest a nuclear intra-
cellular target for CaThi. Finally, our results show that
FLC and CaThi combined causes dramatic morpho-
logical changes in these yeasts, effective against all
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CaThi and FLC is a strong candidate for clinical studies
aiming to improve therapeutic results against resistant
strains of Candida species. Studies involving drug
combinations should be reinforced due to the possibility
of synergistic effects that increase the toxic effect of the
drugs combined when compared to monotherapy. More-
over, drug combinations can broaden the spectrum of
antimicrobial activity, minimizing resistant microorgan-




Capsicum annuum L. fruits (accession UENF1381) were
provided by Laboratório de Melhoramento Genético
Vegetal, from Centro de Ciências e Tecnologias Agrope-
cuárias, Universidade Estadual do Norte Fluminense
Darcy Ribeiro (UENF), Campos dos Goytacazes, Rio de
Janeiro, Brazil.
The yeasts Candida albicans (CE022), Candida tropi-
calis (CE017), and Candida parapsilosis (CE002) were
obtained from Departamento de Biologia, Universidade
Federal do Ceará, Fortaleza, Brazil. The yeasts Candida
pelliculosa (3974), Candida buinensis (3982), and Can-
dida mogii (4674) were obtained from Micoteca URM
from Universidade Federal de Pernambuco, Recife,
Pernambuco, Brazil. Yeasts were maintained on Sabour-
aud agar (1 % peptone, 2 % glucose, and 1.7 % agar-agar)
(Merck) in the Laboratório de Fisiologia e Bioquímica de
Microrganismos, from Centro de Biociência e Biotecnolo-
gia, UENF, Campos dos Goytacazes, Rio de Janeiro,
Brazil.
CaThi
Extraction and purification of the thionin CaThi from
Capsicum annuum fruits by chromatographic methods
were performed as described by Taveira et al. [8]. The
retention time to recover the thionin CaThi during the
reversed-phase chromatography in column μRPC C2/
C18 (ST 4.6/100) (GE Healthcare) was 37.87 min.
Preparation of yeast cells and determination of IC50 for
CaThi and fluconazole
For the preparation of yeast cell cultures, an inoculum
from each stock of Candida albicans, Candida tropica-
lis, Candida parapsilosis, Candida pelliculosa, Candida
buinensis, and Candida mogii was transferred to Petri
dishes containing Sabouraud agar and allowed to grow
at 30 °C for 48 h. After this time, each cell aliquot was
added to 10 mL sterile culture medium (Sabouraud
broth, Merck). The cells were quantified in a Neubauer
chamber (Optik Labor) with the aid of an optical micro-
scope (Axiovison 4, Zeiss). The assay for checking thegrowth inhibition of yeast cells was performed according
to Broekaert et al. [46] with modifications. Initially yeast
cells (1 x 104 cells mL−1) were incubated in Sabouraud
broth containing CaThi at concentrations ranging from
100 μg.mL−1 to 1 μg.mL−1 and fluconazole (FLC) at con-
centrations ranging from 20 μg.ml−1 to 0.125 μg.mL−1,
with the final volume adjusted to 200 μL. The assay was
performed in 96-well microplates (Nunc) at 30 °C for
24 h. Optical readings at 620 nm were recorded at zero
hour and every 6 h interval for 24 h. Control cells were
grown in the absence of CaThi and FLC. The optical
densities were plotted against the concentration of
CaThi and FLC, and then the concentration of the drug
(CaThi and FLC) required for 50 % inhibition (IC50)
in vitro of the tested yeasts was determined. Experiments
were performed in triplicate.
Viability assay
To assay the effect of CaThi on the cell viability of yeasts,
1x104 cells mL−1 in Sabouraud broth culture medium and
at the corresponding IC50 of CaThi values for each yeast
were incubated at 30 °C for 24 h in 96-well microplates
(Nunc). To determine the control viability, the control
cells (without CaThi) were washed once and diluted
1,000–fold in Sabouraud broth culture medium, and an
aliquot of 100 μL from this dilution was spread over the
surface of a Sabouraud agar medium (contained in a Petri
dish) with a Drigalski loop and grown at 30 °C for 48 h. At
the end of this period, colonies forming units (CFU) were
determined for each yeast species, and the Petri dishes
were photographed. The same procedure was followed
with yeasts treated with CaThi. The experiments were car-
ried out in triplicate, and the results are shown assuming
that the control represents 100 % viability. Calculations of
the standard deviation and T test were performed with
Prism software (version 5.0).
Plasma membrane permeabilization assay
The plasma membrane permeabilization of yeast cells
was measured by Sytox green uptake, according to the
methodology described by Thevissen et al. [47], with
some modifications. Each of the different species of
yeasts was incubated with CaThi at the concentration
required to inhibit 50 % growth (IC50) of the respective
yeast cells for 24 h. After this time, a 100 μL aliquot of
each yeast cell suspension was incubated with 0.2 μM of
Sytox green in 1.5 mL microcentrifuge tubes for 30 min
at 25 °C with constant agitation. Cells were analyzed by
DIC optical microscope (Axiovison 4, Zeiss) equipped
with a fluorescent filter set for detection of the
fluorescein (excitation wavelength, 450–490 nm, emis-
sion wavelength 500 nm). To indicate membrane
permeabilization, the percentage of fluorescent cells was
determined by counting the DIC and fluorescent views
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of each yeast (in control and test) was assumed as
100 %. The experiments were carried out in triplicate.
Calculations of T test were performed with Prism soft-
ware (version 5.0).Determining the induction of intracellular ROS in yeast
cells
To evaluate whether the mechanism of action of CaThi
involves induction of oxidative stress, the fluorescent
probe 2 , 7 -dichlorofluorescein diacetate (H2DCFDA)
was used to measure intracellular reactive oxygen
species (ROS) according to the methodology described
by Mello et al. [31]. Each of the different species of
yeasts was incubated with the respective IC50 for CaThi
in 96-well microplates for 24 h at 30 °C; after this incu-
bation an aliquot of 50 μL of each of yeast cell suspen-
sion was incubated with 200 μM of H2DCFDA in micro
centrifuge tubes of 1.5 mL for 1 h at 25 °C with constant
agitation at 500 rpm. Cells were analyzed by DIC optical
microscope (Axiovison 4, Zeiss) equipped with a fluores-
cent filter set for detection of the fluorescein (excitation
wavelength, 450–490 nm, emission wavelength 500 nm).
The experiments were carried out in triplicate.
CaThi conjugated to FITC localization for optical
microscopy
CaThi at 100 μg was resuspended in 100 μL of 750 mM
sodium carbonate-sodium bicarbonate buffer, pH 9.5
containing FITC at 50 μg.mL−1 (previously solubilized in
DMSO). This solution was incubated with constant
agitation at 500 rpm for 2 h at 30 °C. After this incuba-
tion, the sample was submitted to gel filtration chroma-
tography on Sephadex G25 column (Sigma) for
elimination of free FITC and recovery CaThi-FITC. The
column was equilibrated and run with 20 mM Tris–
HCl, pH 8.0 at flow rate of 0.3 mL.mim−1. After
coupling, 10 μg.mL−1 of CaThi-FITC was incubated with
cells of C. albicans and C. tropicalis for 24 h in 96-well
microplates. After this time an aliquot of each cell
suspension was removed and incubated with 50 μg.mL−1
of 4 ,6-diamidino-2-phenylindole dihydrochloride (DAPI)
for 10 min for nuclei stain. Cells were analyzed by
DIC optical microscope (Axiovison 4, Zeiss) equipped
with a fluorescent filter set for detection of the fluor-
escein (excitation wavelength, 450–490 nm, emission
wavelength 500 nm). The entire assay was performed
protected from light.
Synergism assay
To verify the synergistic activities, we combined FLC
with CaThi. Initially yeast cells (1 x 104 cells mL−1) were
incubated in Sabouraud broth containing an IC50concentration or less than that for FLC and CaThi con-
centrations ranging from 1.3 to 4.0 times below the IC50
for the respective yeast and the final volume adjusted to
200 μL in vitro. The assay was performed in 96-well
microplates (Nunc) at 30 °C for 24 h. Optical readings at
620 nm were taken at zero hour and every 6 h for the
following 24 h. Control cells were: 1) grown in the
absence of CaThi and FLC; 2) grown in the presence of
FLC; 3) grown in the presence of CaThi. The synergistic
activity was deduced comparing optical densities of each
control and combined drugs (FLC plus CaThi) consider-
ing each yeast strain tested. We define synergism as the
combination action of the AMP with other substance
that causes an enhanced decrease in the growth of the
microorganism, compared with the growth inhibition of
the single substances. After synergism, assay cells (con-
trols and tests) were analyzed by DIC optical microscope
(Axiovison 4, Zeiss). The data were obtained from exper-
iments performed in triplicate. The data were evaluated
using a one-way ANOVA. Mean differences at p < 0.05
were considered to be significant. All statistical analyses
were performed using the GraphPad Prism software
(version 5.0 for Windows).
Scanning electron microscopy
C. pelliculosa and C. buinensis cells were submitted to
scanning electron microscopy (SEM) analysis. Yeast cells
were grown for 24 h in Sabouraud broth in the presence
of FLC (5 μg.mL−1 and 0.125 μg.mL−1, respectively),
CaThi (40 μg.mL−1 and 10 μg.mL−1, respectively), and
FLC plus CaThi (2.5 μg.mL−1 + 15 μg.mL−1,
0.06 μg.mL−1 + 5 μg.mL−1, respectively) or absence of
these drugs, then were fixed for 30 min at 30 °C in a
solution containing 2.5 % glutaraldehyde and 4.0 %
formaldehyde in 0.1 M cacodylate buffer, pH 7.0. Sub-
sequently, the cells were rinsed three times in 0.1 M
cacodylate buffer, pH 7.0; post-fixed for 30 min at
30 °C with 1.0 % osmium tetroxide diluted in 0.1 M
cacodylate buffer, pH 7.0; and rinsed again with this
same buffer. The yeast cells were gradually dehy-
drated in alcohol solution (15, 30, 50, 70 to 90 % and
finally 100 % alcohol), critical point dried in CO2,
covered with 20 nm gold and observed in a DSEM
962 Zeiss SEM.
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